// App-Quantinova.ai

2699 : A cancer treatment based on synergy between anti-angiogenic and immune cell therapies

Researchers

Presenter

  • Luis F. Soto-Ortiz

Principal Investigators

  • N/A

Medical Centers

  • East Los Angeles College, Monterey Park, CA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cluster of differentiation 8A

  • Vascular endothelial growth factor A

Drug/Treatment

  • Bevacizumab

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved